Cargando…
Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study
BACKGROUND: We compared the prognostic value of serum high mobility group box 1 protein (HMGB1) and histone H3 levels with the International Society on Thrombosis and Haemostasis (ISTH) disseminated intravascular coagulation (DIC) scores for 28-day in-hospital mortality in patients with DIC caused b...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190102/ https://www.ncbi.nlm.nih.gov/pubmed/35698137 http://dx.doi.org/10.1186/s12959-022-00390-2 |
_version_ | 1784725724105539584 |
---|---|
author | Mori, Hirotaka Kataoka, Yuki Harada-Shirado, Kayo Kawano, Noriaki Hayakawa, Mineji Seki, Yoshinobu Uchiyama, Toshimasa Yamakawa, Kazuma Ishikura, Hiroyasu Irie, Yuhei Nishio, Kenji Yada, Noritaka Okamoto, Kohji Yamada, Shingo Ikezoe, Takayuki |
author_facet | Mori, Hirotaka Kataoka, Yuki Harada-Shirado, Kayo Kawano, Noriaki Hayakawa, Mineji Seki, Yoshinobu Uchiyama, Toshimasa Yamakawa, Kazuma Ishikura, Hiroyasu Irie, Yuhei Nishio, Kenji Yada, Noritaka Okamoto, Kohji Yamada, Shingo Ikezoe, Takayuki |
author_sort | Mori, Hirotaka |
collection | PubMed |
description | BACKGROUND: We compared the prognostic value of serum high mobility group box 1 protein (HMGB1) and histone H3 levels with the International Society on Thrombosis and Haemostasis (ISTH) disseminated intravascular coagulation (DIC) scores for 28-day in-hospital mortality in patients with DIC caused by various underlying diseases. METHODS: We conducted a multicenter prospective cohort study including two hematology departments, four emergency departments, and one general medicine department in Japan, between August 2017 and July 2021. We included patients diagnosed with DIC by the ISTH DIC scoring system. RESULTS: Overall, 104 patients were included: 50 with hematopoietic disorders, 41 with infections, and 13 with the other diseases. The 28-day in-hospital mortality rate was 21%. The receiver operator characteristic (ROC) curve showed that a DIC score of 6 points, serum HMGB1 level of 8 ng/mL, and serum histone H3 level of 2 ng/mL were the optimal cutoff points. The odds ratios of more than these optimal cutoff points of the DIC score, serum HMGB1, and histone H3 levels were 1.58 (95% confidence interval [CI]: 0.60 to 4.17, p = 0.36), 5.47 (95% CI: 1.70 to 17.6, p = 0.004), and 9.07 (95% CI: 2.00 to 41.3, p = 0.004), respectively. The area under the ROC curve of HMGB1 (0.74, 95% CI: 0.63 to 0.85) was better than that of the ISTH DIC scores (0.55, 95% CI: 0.43 to 0.67, p = 0.03), whereas that of histone H3 was not (0.71, 95% CI: 0.60 to 0.82, p = 0.07). Calibration and net reclassification plots of HMGB1 identified some high-risk patients, whereas the ISTH DIC scores and histone H3 did not. The category-free net reclassification improvement of HMGB1 was 0.45 (95% CI: 0.01 to 0.90, p = 0.04) and that of histone H3 was 0.37 (95% CI: − 0.05 to 0.78, p = 0.08). CONCLUSIONS: Serum HMGB1 levels have a prognostic value for mortality in patients with DIC. This finding may help physicians develop treatment strategies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12959-022-00390-2. |
format | Online Article Text |
id | pubmed-9190102 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-91901022022-06-14 Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study Mori, Hirotaka Kataoka, Yuki Harada-Shirado, Kayo Kawano, Noriaki Hayakawa, Mineji Seki, Yoshinobu Uchiyama, Toshimasa Yamakawa, Kazuma Ishikura, Hiroyasu Irie, Yuhei Nishio, Kenji Yada, Noritaka Okamoto, Kohji Yamada, Shingo Ikezoe, Takayuki Thromb J Research BACKGROUND: We compared the prognostic value of serum high mobility group box 1 protein (HMGB1) and histone H3 levels with the International Society on Thrombosis and Haemostasis (ISTH) disseminated intravascular coagulation (DIC) scores for 28-day in-hospital mortality in patients with DIC caused by various underlying diseases. METHODS: We conducted a multicenter prospective cohort study including two hematology departments, four emergency departments, and one general medicine department in Japan, between August 2017 and July 2021. We included patients diagnosed with DIC by the ISTH DIC scoring system. RESULTS: Overall, 104 patients were included: 50 with hematopoietic disorders, 41 with infections, and 13 with the other diseases. The 28-day in-hospital mortality rate was 21%. The receiver operator characteristic (ROC) curve showed that a DIC score of 6 points, serum HMGB1 level of 8 ng/mL, and serum histone H3 level of 2 ng/mL were the optimal cutoff points. The odds ratios of more than these optimal cutoff points of the DIC score, serum HMGB1, and histone H3 levels were 1.58 (95% confidence interval [CI]: 0.60 to 4.17, p = 0.36), 5.47 (95% CI: 1.70 to 17.6, p = 0.004), and 9.07 (95% CI: 2.00 to 41.3, p = 0.004), respectively. The area under the ROC curve of HMGB1 (0.74, 95% CI: 0.63 to 0.85) was better than that of the ISTH DIC scores (0.55, 95% CI: 0.43 to 0.67, p = 0.03), whereas that of histone H3 was not (0.71, 95% CI: 0.60 to 0.82, p = 0.07). Calibration and net reclassification plots of HMGB1 identified some high-risk patients, whereas the ISTH DIC scores and histone H3 did not. The category-free net reclassification improvement of HMGB1 was 0.45 (95% CI: 0.01 to 0.90, p = 0.04) and that of histone H3 was 0.37 (95% CI: − 0.05 to 0.78, p = 0.08). CONCLUSIONS: Serum HMGB1 levels have a prognostic value for mortality in patients with DIC. This finding may help physicians develop treatment strategies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12959-022-00390-2. BioMed Central 2022-06-13 /pmc/articles/PMC9190102/ /pubmed/35698137 http://dx.doi.org/10.1186/s12959-022-00390-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Mori, Hirotaka Kataoka, Yuki Harada-Shirado, Kayo Kawano, Noriaki Hayakawa, Mineji Seki, Yoshinobu Uchiyama, Toshimasa Yamakawa, Kazuma Ishikura, Hiroyasu Irie, Yuhei Nishio, Kenji Yada, Noritaka Okamoto, Kohji Yamada, Shingo Ikezoe, Takayuki Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study |
title | Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study |
title_full | Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study |
title_fullStr | Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study |
title_full_unstemmed | Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study |
title_short | Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study |
title_sort | prognostic value of serum high mobility group box 1 protein and histone h3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190102/ https://www.ncbi.nlm.nih.gov/pubmed/35698137 http://dx.doi.org/10.1186/s12959-022-00390-2 |
work_keys_str_mv | AT morihirotaka prognosticvalueofserumhighmobilitygroupbox1proteinandhistoneh3levelsinpatientswithdisseminatedintravascularcoagulationamulticenterprospectivecohortstudy AT kataokayuki prognosticvalueofserumhighmobilitygroupbox1proteinandhistoneh3levelsinpatientswithdisseminatedintravascularcoagulationamulticenterprospectivecohortstudy AT haradashiradokayo prognosticvalueofserumhighmobilitygroupbox1proteinandhistoneh3levelsinpatientswithdisseminatedintravascularcoagulationamulticenterprospectivecohortstudy AT kawanonoriaki prognosticvalueofserumhighmobilitygroupbox1proteinandhistoneh3levelsinpatientswithdisseminatedintravascularcoagulationamulticenterprospectivecohortstudy AT hayakawamineji prognosticvalueofserumhighmobilitygroupbox1proteinandhistoneh3levelsinpatientswithdisseminatedintravascularcoagulationamulticenterprospectivecohortstudy AT sekiyoshinobu prognosticvalueofserumhighmobilitygroupbox1proteinandhistoneh3levelsinpatientswithdisseminatedintravascularcoagulationamulticenterprospectivecohortstudy AT uchiyamatoshimasa prognosticvalueofserumhighmobilitygroupbox1proteinandhistoneh3levelsinpatientswithdisseminatedintravascularcoagulationamulticenterprospectivecohortstudy AT yamakawakazuma prognosticvalueofserumhighmobilitygroupbox1proteinandhistoneh3levelsinpatientswithdisseminatedintravascularcoagulationamulticenterprospectivecohortstudy AT ishikurahiroyasu prognosticvalueofserumhighmobilitygroupbox1proteinandhistoneh3levelsinpatientswithdisseminatedintravascularcoagulationamulticenterprospectivecohortstudy AT irieyuhei prognosticvalueofserumhighmobilitygroupbox1proteinandhistoneh3levelsinpatientswithdisseminatedintravascularcoagulationamulticenterprospectivecohortstudy AT nishiokenji prognosticvalueofserumhighmobilitygroupbox1proteinandhistoneh3levelsinpatientswithdisseminatedintravascularcoagulationamulticenterprospectivecohortstudy AT yadanoritaka prognosticvalueofserumhighmobilitygroupbox1proteinandhistoneh3levelsinpatientswithdisseminatedintravascularcoagulationamulticenterprospectivecohortstudy AT okamotokohji prognosticvalueofserumhighmobilitygroupbox1proteinandhistoneh3levelsinpatientswithdisseminatedintravascularcoagulationamulticenterprospectivecohortstudy AT yamadashingo prognosticvalueofserumhighmobilitygroupbox1proteinandhistoneh3levelsinpatientswithdisseminatedintravascularcoagulationamulticenterprospectivecohortstudy AT ikezoetakayuki prognosticvalueofserumhighmobilitygroupbox1proteinandhistoneh3levelsinpatientswithdisseminatedintravascularcoagulationamulticenterprospectivecohortstudy |